These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36803092)

  • 1. Gut microbiome-based strategies for host health and disease.
    Wang C; Bai J; Chen X; Song J; Zhang Y; Wang H; Suo H
    Crit Rev Food Sci Nutr; 2024; 64(19):6834-6849. PubMed ID: 36803092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiomes in physiology: insights into 21st-century global medical challenges.
    Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
    Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach.
    Chowdhury M; Raj Chaudhary N; Kaur P; Goyal A; Sahu SK
    Infect Disord Drug Targets; 2024; 24(5):e160124225675. PubMed ID: 38317473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unveiling and harnessing the human gut microbiome in the rising burden of non-communicable diseases during urbanization.
    Huang Z; Li Y; Park H; Ho M; Bhardwaj K; Sugimura N; Lee HW; Meng H; Ebert MP; Chao K; Burgermeister E; Bhatt AP; Shetty SA; Li K; Wen W; Zuo T
    Gut Microbes; 2023; 15(1):2237645. PubMed ID: 37498052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leveraging diet to engineer the gut microbiome.
    Wolter M; Grant ET; Boudaud M; Steimle A; Pereira GV; Martens EC; Desai MS
    Nat Rev Gastroenterol Hepatol; 2021 Dec; 18(12):885-902. PubMed ID: 34580480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics, Prebiotics, Fecal Microbiota Transplantation, and Dietary Patterns in Inflammatory Bowel Disease.
    Noguera-Fernández N; Candela-González J; Orenes-Piñero E
    Mol Nutr Food Res; 2024 Sep; 68(18):e2400429. PubMed ID: 39194379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the role of the human gut microbiome in overweight and obesity.
    McBurney MI; Cho CE
    Ann N Y Acad Sci; 2024 Oct; 1540(1):61-88. PubMed ID: 39283061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal involvement of autism spectrum disorder: focus on gut microbiota.
    Settanni CR; Bibbò S; Ianiro G; Rinninella E; Cintoni M; Mele MC; Cammarota G; Gasbarrini A
    Expert Rev Gastroenterol Hepatol; 2021 Jun; 15(6):599-622. PubMed ID: 33356668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of the Gut Microbiome for Viral Diarrheal and Extra-Intestinal Diseases.
    Desselberger U
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the human gut microbiota in colonization and infection with multidrug-resistant bacteria.
    Wuethrich I; W Pelzer B; Khodamoradi Y; Vehreschild MJGT
    Gut Microbes; 2021; 13(1):1-13. PubMed ID: 33870869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota: a target for intervention in obesity.
    Sehgal K; Khanna S
    Expert Rev Gastroenterol Hepatol; 2021 Oct; 15(10):1169-1179. PubMed ID: 34329563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
    Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
    Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis.
    Kujawa D; Laczmanski L; Budrewicz S; Pokryszko-Dragan A; Podbielska M
    Gut Microbes; 2023 Dec; 15(2):2274126. PubMed ID: 37979154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The triple interactions between gut microbiota, mycobiota and host immunity.
    Yang J; Yang H; Li Y
    Crit Rev Food Sci Nutr; 2023 Nov; 63(33):11604-11624. PubMed ID: 35776086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
    Haak BW; Prescott HC; Wiersinga WJ
    Front Immunol; 2018; 9():2042. PubMed ID: 30250472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care.
    Ciernikova S; Sevcikova A; Drgona L; Mego M
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188990. PubMed ID: 37742728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From role of gut microbiota to microbial-based therapies in type 2-diabetes.
    Ebrahimzadeh Leylabadlo H; Sanaie S; Sadeghpour Heravi F; Ahmadian Z; Ghotaslou R
    Infect Genet Evol; 2020 Jul; 81():104268. PubMed ID: 32126303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome-targeted therapies for Alzheimer's disease.
    Zhang T; Gao G; Kwok LY; Sun Z
    Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut dysbacteriosis and intestinal disease: mechanism and treatment.
    Meng X; Zhang G; Cao H; Yu D; Fang X; de Vos WM; Wu H
    J Appl Microbiol; 2020 Oct; 129(4):787-805. PubMed ID: 32277534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management?
    Mehmood K; Moin A; Hussain T; Rizvi SMD; Gowda DV; Shakil S; Kamal MA
    Folia Microbiol (Praha); 2021 Dec; 66(6):897-916. PubMed ID: 34699042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.